BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boia R, Ruzafa N, Aires ID, Pereiro X, Ambrósio AF, Vecino E, Santiago AR. Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead. Int J Mol Sci 2020;21:E2262. [PMID: 32218163 DOI: 10.3390/ijms21072262] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Galindo-Romero C, Vidal-Villegas B, Asís-Martínez J, Lucas-Ruiz F, Gallego-Ortega A, Vidal-Sanz M. 7,8-Dihydroxiflavone Protects Adult Rat Axotomized Retinal Ganglion Cells through MAPK/ERK and PI3K/AKT Activation. Int J Mol Sci 2021;22:10896. [PMID: 34639236 DOI: 10.3390/ijms221910896] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Aloe L, Rocco ML, Balzamino BO, Esposito G, Micera A. Retrobulbar administration of purified anti-nerve growth factor in developing rats induces structural and biochemical changes in the retina and cornea. Int J Ophthalmol 2021;14:209-16. [PMID: 33614448 DOI: 10.18240/ijo.2021.02.05] [Reference Citation Analysis]
3 Markitantova YV, Simirskii VN. The Role of the Purinergic Signaling System in the Control of Histogenesis, Homeostasis, and Pathogenesis of the Vertebrate Retina. Russ J Dev Biol 2021;52:430-48. [DOI: 10.1134/s1062360421060084] [Reference Citation Analysis]
4 Behtaj S, Rybachuk M. Strategies on the application of stem cells based therapies for the treatment of optic neuropathies. Neural Regen Res 2021;16:1190-1. [PMID: 33269770 DOI: 10.4103/1673-5374.300343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pérez Y, Bonet R, Corredor M, Domingo C, Moure A, Messeguer À, Bujons J, Alfonso I. Semaphorin 3A-Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration. Pharmaceuticals (Basel) 2021;14:906. [PMID: 34577606 DOI: 10.3390/ph14090906] [Reference Citation Analysis]
6 Fiore L, Carreño CO, Medori M, Spelzini G, Sanchez V, Scicolone G. Neurospheres obtained from the ciliary margin of the chicken eye possess positional values and retinal ganglion cells differentiated from them respond to EphA/ephrin-A system. Experimental Eye Research 2022. [DOI: 10.1016/j.exer.2022.108965] [Reference Citation Analysis]
7 Skopiński P, Radomska-Leśniewska DM, Izdebska J, Kamińska A, Kupis M, Kubiak AJ, Samelska K. New perspectives of immunomodulation and neuroprotection in glaucoma. Cent Eur J Immunol 2021;46:105-10. [PMID: 33897291 DOI: 10.5114/ceji.2021.104329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tribble JR, Hui F, Jöe M, Bell K, Chrysostomou V, Crowston JG, Williams PA. Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma. Cells 2021;10:295. [PMID: 33535578 DOI: 10.3390/cells10020295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Korn P, Gellrich NC, Spalthoff S, Jehn P, Eysel UT, Zerfowski M. Evaluation of the neuroprotective effects of methylprednisolone and surgical decompression in a rodent model of traumatic optic neuropathy. Curr Eye Res 2021. [PMID: 34696640 DOI: 10.1080/02713683.2021.1998544] [Reference Citation Analysis]
10 Yoo HS, Shanmugalingam U, Smith PD. Harnessing Astrocytes and Müller Glial Cells in the Retina for Survival and Regeneration of Retinal Ganglion Cells. Cells 2021;10:1339. [PMID: 34071545 DOI: 10.3390/cells10061339] [Reference Citation Analysis]
11 Sharif NA. Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies. Front Pharmacol 2021;12:729249. [PMID: 34603044 DOI: 10.3389/fphar.2021.729249] [Reference Citation Analysis]
12 Aires ID, Ribeiro-Rodrigues T, Boia R, Ferreira-Rodrigues M, Girão H, Ambrósio AF, Santiago AR. Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading. Biomolecules 2021;11:770. [PMID: 34063832 DOI: 10.3390/biom11060770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Schnichels S, Paquet-Durand F, Löscher M, Tsai T, Hurst J, Joachim SC, Klettner A. Retina in a dish: Cell cultures, retinal explants and animal models for common diseases of the retina. Prog Retin Eye Res 2021;81:100880. [PMID: 32721458 DOI: 10.1016/j.preteyeres.2020.100880] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
14 Claes M, Geeraerts E, Plaisance S, Mentens S, Van den Haute C, De Groef L, Arckens L, Moons L. Chronic Chemogenetic Activation of the Superior Colliculus in Glaucomatous Mice: Local and Retrograde Molecular Signature. Cells 2022;11:1784. [DOI: 10.3390/cells11111784] [Reference Citation Analysis]
15 Carrella S, Indrieri A, Franco B, Banfi S. Mutation-Independent Therapies for Retinal Diseases: Focus on Gene-Based Approaches. Front Neurosci 2020;14:588234. [PMID: 33071752 DOI: 10.3389/fnins.2020.588234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wareham LK, Risner ML, Calkins DJ. Protect, Repair, and Regenerate: Towards Restoring Vision in Glaucoma. Curr Ophthalmol Rep 2020;8:301-10. [PMID: 33269115 DOI: 10.1007/s40135-020-00259-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
17 Aires ID, Santiago AR. Microglial exosomes in retinal neuroinflammation: focus in glaucoma. Neural Regen Res 2021;16:1801-2. [PMID: 33510084 DOI: 10.4103/1673-5374.306084] [Reference Citation Analysis]
18 Shen J, Wang Y, Yao K. Protection of retinal ganglion cells in glaucoma: Current status and future. Exp Eye Res 2021;205:108506. [PMID: 33609512 DOI: 10.1016/j.exer.2021.108506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Boia R, Dias PA, Galindo-romero C, Ferreira H, Aires ID, Vidal-sanz M, Agudo-barriuso M, Bernardes R, Santos PF, de Sousa HC, Ambrósio AF, Braga ME, Santiago AR. Intraocular implants loaded with A3R agonist rescue retinal ganglion cells from ischemic damage. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Yang N, Yang J, He X, Zhang W, Xing Y. Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury. Exp Eye Res 2021;215:108915. [PMID: 34971620 DOI: 10.1016/j.exer.2021.108915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Lee HL, Yeum CE, Lee H, Oh J, Kim JT, Lee WJ, Ha Y, Yang YI, Kim KN. Peripheral Nerve-Derived Stem Cell Spheroids Induce Functional Recovery and Repair after Spinal Cord Injury in Rodents. Int J Mol Sci 2021;22:4141. [PMID: 33923671 DOI: 10.3390/ijms22084141] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang KY, Aguzzi EA, Johnson TV. Retinal Ganglion Cell Transplantation: Approaches for Overcoming Challenges to Functional Integration. Cells 2021;10:1426. [PMID: 34200991 DOI: 10.3390/cells10061426] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 da Silva-Junior AJ, Mesentier-Louro LA, Nascimento-Dos-Santos G, Teixeira-Pinheiro LC, Vasques JF, Chimeli-Ormonde L, Bodart-Santos V, de Carvalho LRP, Santiago MF, Mendez-Otero R. Human mesenchymal stem cell therapy promotes retinal ganglion cell survival and target reconnection after optic nerve crush in adult rats. Stem Cell Res Ther 2021;12:69. [PMID: 33468246 DOI: 10.1186/s13287-020-02130-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Sobot V, Stamenkovic M, Simic T, Jerotic D, Djokic M, Jaksic V, Bozic M, Milic J, Savic-Radojevic A, Djukic T. Association of GSTO1, GSTO2, GSTP1, GPX1 and SOD2 polymorphism with primary open angle glaucoma. Exp Eye Res 2021;214:108863. [PMID: 34826418 DOI: 10.1016/j.exer.2021.108863] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]